Absolute Return Capital’s Avanos Medical AVNS Stock Holding History

Absolute Return Capital’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-11,312	Closed	-$458K	–	513
2015 Q2	$458K	Buy	11,312 +1,147	+11%	+$51.5K	0.02%	430
2015 Q1	$500K	Sell	10,165 -24,841	-71%	-$1.15M	0.01%	485
2014 Q4	$1.59M	Buy	+35,006	New	+$1.38M	0.03%	384

Other funds holding AVNS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

SCM

Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Absolute Return Capital's AVNS Position: Q3 2015 in Review

Absolute Return Capital sold out of Avanos Medical (AVNS) in Q3 2015, closing a stake of 11,312 shares — an estimated $458K sold.

Absolute Return Capital first reported a position in AVNS in Q4 2014 and held it in 3 quarters. The position peaked at $1.59M in Q4 2014. 352 funds tracked by Wall St. Rank hold AVNS as of Q3 2015.

Absolute Return Capital reported no remaining Avanos Medical position as of Q3 2015 after selling out during the quarter.
Absolute Return Capital sold 11,312 Avanos Medical shares in Q3 2015, an estimated $458K.
Absolute Return Capital first reported a position in Avanos Medical in Q4 2014 and held it in 3 quarters.
Absolute Return Capital's Avanos Medical position peaked at $1.59M in Q4 2014.
352 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2015.

Based on Absolute Return Capital's 13F filing for Q3 2015, filed 13 Nov 2015.